Related Experiment Video
Updated: Feb 10, 2026

Personalized Needles for Microinjections in the Rodent Brain
Published on: January 24, 2018
Towards personalized cell-replacement therapies for brain repair
Alexandros A Lavdas1, Rebecca Matsas1
1Laboratory of Cellular and Molecular Neurobiology, Hellenic Pasteur Institute, 127 Vassilissis Sofias Avenue, 11521 Athens, Greece. rmatsa@pasteur.gr.
Developing new therapies is crucial for central nervous system (CNS) repair. This review explores stem cell therapies, including induced pluripotent stem cells, for treating CNS injuries and demyelination.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Central nervous system (CNS) damage from trauma or disease is difficult to repair.
- Cell transplantation and myelin repair are key therapeutic strategies.
- Existing treatments for CNS injuries and demyelination are limited.
Purpose of the Study:
- To review the potential of cell replacement therapies for CNS repair.
- To discuss the use of stem cells and peripheral nervous system (PNS) glial cells.
- To highlight advancements in induced pluripotent stem cells (iPSCs) for personalized therapies.
Main Methods:
- Review of current literature on cell transplantation for CNS repair.
- Analysis of stem cell sources, including PNS glial cells and olfactory ensheathing cells.
- Evaluation of induced pluripotent stem cell (iPSC) technology and its applications.
Main Results:
- Stem cells and PNS glial cells show promise for neuronal replacement and remyelination.
- Induced pluripotent stem cells (iPSCs) offer a pathway to personalized cell therapies.
- Olfactory ensheathing cells present unique potential for CNS repair.
Conclusions:
- Cell-based therapies hold significant promise for treating CNS damage.
- Induced pluripotent stem cells (iPSCs) represent a major advancement in regenerative medicine.
- Further research is needed to optimize cell therapies for clinical application.
More Related Videos
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
09:34Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
Published on: May 18, 2017
Related Concept Videos
Continuous Renal Replacement Therapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Gene Therapy
Mismatch Repair
Overview of DNA Repair
Chemically...